• Celldex Therapeutics (NASDAQ:CLDX) Reaches New 52-Week Low Following Analyst Downgrade

    Source: Buzz FX / 03 Mar 2025 13:31:15   America/Chicago


    Celldex Therapeutics (NASDAQ:CLDX) Reaches New 52-Week Low Following Analyst Downgrade Written by MarketBeat March 3, 2025 Share Link copied to clipboard. Shares of Celldex Therapeutics, Inc. ( NASDAQ:CLDX - Get Free Report ) hit a new 52-w
    Read more...
Share on,